|
|||||
|
|
[2'',5''-Bis-O-(tert-butyldimethylsilyl)]-3''-spiro-5''''-(4''''-amino-1'''',2''''-oxathiole-2'''',2''''-dioxide) (TSAO) derivatives of purine and pyrimidinenucleosides as potent and selective inhibitors of human immunodeficiency virus type 1. |
|
| Authors: | J Balzarini, M J P rez-P rez, A San-F lix, S Velazquez, M J Camarasa, E De Clercq |
| Affiliation: | Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium. |
| Abstract: | |
| Keywords: | |